Intravenous nicotine in Alzheimer's dise
β
P. A. Newhouse; T. Sunderland; P. N. Tariot; C. L. Blumhardt; H. Weingartner; A.
π
Article
π
1988
π
Springer
π
English
β 549 KB
In the tu'st study to examine direct nicotinic augmentation of central cholinergic functioning in Alzheimer's disease, six patients were studied in an intensive pilot study with three doses (0.125, 0.25, and 0.5 I~g/kg/min) of intravenous nicotine and placebo. Cognitive tests showed a decrease in in